In the last few years, we have seen an uptick in behavioral health groups focused on psychedelic treatments. Ketamine remains a controlled substance and ketamine behavioral health remains an industry with material regulatory risks.
In the last few years, we have seen an uptick in behavioral health groups focused on psychedelic treatments. There are now at least five (5) psychedelic-assisted therapy platforms.